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Retinal tissue thickness is reduced in diabetic peripheral neuropathy 
OBJECTIVES 
METHODS 
Research question 
RESULTS 
DISCUSSION 
 Retinal tissue integrity in relation to diabetic neuropathy is 
incompletely defined1 
 This study was designed to investigate retinal tissue thickness in 
relation to diabetic peripheral neuropathy in individuals with diabetes 
Study design: Cross-sectional, age-balanced, case-controlled evaluation 
of full retinal and inner retinal thickness in individuals with type 1 or type 
2 diabetes, with or without neuropathy 
 Participants 
 44 individuals with diabetes and neuropathy  
 107 individuals with diabetes and no neuropathy  
 45 individuals without diabetes or neuropathy (controls) 
 Inclusion criteria  
 Best corrected visual acuity better than 6/9.5  
 Spherical refractive error within 6.00 D and astigmatism within 3.00 D  
 IOP ≤ 22 mmHg  
 H/V cup-disc ratio ≤ 0.6  
 Eye on the hand-dominant side was tested 
 Diabetic neuropathy defined using Neuropathy Disability Score (NDS) 
on a scale of 0-10, where NDS ≥ 3 is designated as neuropathy2 
 Full retinal and inner retinal thickness (RNFL, GCC) assessed with 
RTVue spectral-domain OCT 
 
 
 
 
 Relationship between diabetic neuropathy and foveal, parafoveal and 
perifoveal retinal thickness and inner retinal thickness, adjusted for: 
 diabetic retinopathy  
 age 
 sex  
 HbA1c levels  
 duration of diabetes, in individuals with diabetes 
 A p-value of < 0.05 was considered statistically significant 
Are the full retinal thickness and inner retinal thickness reduced in 
relation to diabetic peripheral neuropathy? 
 
Retinal nerve fibre 
layer thickness 
(RNFL) 
Inner retinal layer 
thickness (GCC) and  
full retinal thickness 
Table 1. Key variables in the neuropathy, no neuropathy and control groups 
 Diabetic peripheral neuropathy affects distal nerves first and then 
progresses to involve proximal nerves (e.g. in the legs).3 The perifovea 
is distal whereas parafovea is relatively proximal. It is possible that this 
pattern similar to that seen elsewhere in the body in neuropathy is also 
observed in the eye, with the perifovea involved initially 
 Findings in perifovea may represent changes in the outer retinal layers 
as perifovea mainly comprises of RPE and photoreceptors.4 Since 
neuropathy predominantly involves damage to the sensory receptors in 
the distal leg, changes in the perifovea likely represent compromise to 
photoreceptors in the retina in relation to neuropathy 
 Loss in retinal layers may be mirrored as loss in visual function (not 
assessed here). May represent second threat to vision integrity 
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RESULTS 
 Perifovea and RNFL thickness was reduced in relation to increasing 
severity of neuropathy 
 Thickness in parafovea was reduced in relation to DR 
 Retinal tissue thickness reduced with advancing age 
Table 2. Retinal tissue thickness in the neuropathy, no neuropathy and control groups. Markers are mean, 
error bars are 95% CI 
RTVue spectral domain OCT 
 Reduced perifovea and RNFL thickness were explained by increasing 
severity of neuropathy, adjusted for DR, age, sex, duration of diabetes, 
HbA1c levels in individuals with diabetes 
‡ Significant differences between neuropathy and no neuropathy groups;  
§ Significant differences between both diabetic versus non-diabetic groups; Data for duration of DM and NDS are median;  
٭ Significant with Mann-Whitney U test; ǁ Significant with chi-square test; Proportion of males compared between diabetic groups 
 For every unit increase in NDS, perifoveal thickness reduced by 1.17 µm and 
RNFL thickness by 1.20 µm 
Variables 
Neuropathy 
(n=44) 
No neuropathy 
(n=107) 
Controls 
(n=45) 
p-values  
Mean ± SD Mean ± SD Mean ± SD 
Min - Max Min - Max Min - Max 
Age 
59.9 ± 8.4 55.2 ± 9.4 55.9 ± 9.6 
0.021 ‡ 
41.0 - 71.6 40.1 - 77.3 40.7 - 72.6 
Males, n (%) 30 (68%) 58 (54%) 20 (44%) 0.114 ǁ 
HbA1c (%) 
8.0 ± 1.3 7.7 ± 1.3 5.4 ± 0.3 
<0.001 § 
6 - 13 5 - 12 5 - 6 
Duration of 19 13 
n/a <0.001 ٭ 
diabetes (yrs) 6 - 64 1 - 53 
NDS  
4.5 0 0 
<0.001 ‡§ 
3 - 10 0 - 2 0 - 2 
DR, n (%) 27 (61%) 36 (34%) n/a 0.002 ǁ 
* Significant differences 
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